Brian New has been a member of the CBS 11 News team since 2013. In 2017, he was awarded the Lone Star Emmy for best investigative reporter. This is one of 10 Emmy awards Brian has been honored with ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

Home Sleep Apnea Testing Devices Market · GlobeNewswire Inc. Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "Home Sleep Apnea Testing Devices - Global Strategic Business Report" has been added to ...

Add Yahoo as a preferred source to see more of our stories on Google. TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...

Standard treatment for obstructive sleep apnea has long relied on continuous positive airway pressure machines, but new ...

Oura Health Oy, the popular smart ring maker seeking to go public this year, unveiled a significantly thinner and lighter new ...

Delray Beach, FL, May 05, 2026 (GLOBE NEWSWIRE)-- The global sleep apnea devices market was valued at USD 6.47 billion in 2024 and reached USD 6.93 billion in 2025. It is expected to grow at a strong ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

TYPE OF SLEEP APNEA. RESTLESS SLEEP AT NIGHT CAN AFFECT YOUR ENTIRE DAY. THERE ARE MANY REASONS WHY YOU MAY NOT BE GETTING ENOUGH SHUT EYE RANGING FROM INSOMNIA, STRESS, OR EVEN SLEEP APNEA. SLEEP ...

The Food and Drug Administration said 561 deaths are reportedly tied to recalled sleep apnea devices made by Philips Respironics. This comes as Philips Respironics this week agreed to stop selling new ...

Medicare Part B covers the cost of Inspire for sleep apnea and other FDA-approved medical devices as long as a doctor determines them to be medically essential for your care. For Original Medicare to ...

May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...